Market Research

MEA Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 232 Pages Data Bridge Market Research September, 2022 DAABD17403920
Best Price Guarantee
Price from $3,500
Length 232 Pages
Publisher Data Bridge Market Research
Published Date September, 2022
SKU DAABD17403920

MEA Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

Middle East molecular point of care testing (using NAAT) market is projected to register a substantial CAGR of 7.4% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.

Market Segmentation
Middle East Molecular point of care testing (using NAAT) Market, By Product (Instruments and Consumables & Reagents), Indication (Respiratory Infections Testing, Sexually Transmitted Infection (STI) Testing, Gastrointestinal Tract Infections Testing, and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East) – Industry Trends and Forecast to 2028

Some of the significant factors contributing to the growth of the Middle East molecular point of care testing (using NAAT) market are:

• Increasing prevalence of chronic diseases
• Improving diagnosis-seeking rate
• Rising preference for homecare testing

Market Players

The key market players operating in the Middle East molecular point of care testing (using NAAT) market are listed below:

• SD Biosensor, Inc.
• Abbott
• F.Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc
• Meridian Bioscience
• BD
• Biomérieux Sa
• Qiagen
• Quidel Corporation
• Bio-Rad Laboratories, Inc.
• GenMark Diagnostics
• Seegene Inc.
• Grifols S.A.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Multivariate Modelling
2.8 Distribution Channel Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market End User Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porters Five Forces
4.2 Pestel Analysis
4.3 Annual Test Volume: For All Countries
4.3.1 Cepheid
4.3.2 Thermo Fisher Scientific Inc.
4.3.3 Hologic, Inc.
4.3.4 Bd
4.3.5 F. Hoffmann-la Roche Ltd
4.4 Number Of Poct Instruments Installed In Each Country
4.5 Distributors
4.5.1 North America
4.5.2 Europe
4.5.3 South Asia
4.5.4 South East Asia
4.5.5 Middle East
4.5.6 Africa
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Increasing Prevalence Of Chronic Diseases
6.1.2 Improving Diagnosis Seeking Rate
6.1.3 Rising Technological Advancements
6.1.4 Rising Geriatric Population Across Globe
6.1.5 Rising Preference For Homecare Testing
6.2 Restraints
6.2.1 Product Recalls
6.2.2 High Costs Of Products
6.2.3 Non-availability Of Relevant And Appropriate Kits
6.3 Opportunities
6.3.1 Strategic Initiatives Taken By Market Players
6.3.2 Rising Healthcare Expenditure
6.3.3 Pandemic Outbreak Of Covid-19
6.3.4 Growing Demand For Better Quality Healthcare And Early Diagnosis
6.4 Challenges
6.4.1 Lack Of Alignment With Test Results Obtained From Laboratories
6.4.2 Lack Of Accessibility
7 Impact Of Covid-19 On The Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Key Initiatives By Market Players During The Covid 19
7.5 Conclusion:
8 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Product
8.1 Overview
8.2 Consumables & Reagents
8.3 Instruments
8.3.1 Mobile Platform (Small & Portable)
8.3.2 Facility-based Platforms (Large Poct Platform)
9 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Indication
9.1 Overview
9.2 Respiratory Infections Testing
9.2.1 Covid-19
9.2.2 Flu B
9.2.3 Flu A
9.2.4 Rsv
9.2.5 Tuberculosis
9.2.6 Pneumonia (Pneumococcal Pneumonia)
9.2.7 Others
9.3 Sexually Transmitted Infection (Sti) Testing
9.3.1 Tv
9.3.2 Ct
9.3.3 Ng
9.3.4 Hpv
9.3.5 Hsv
9.3.6 Mg
9.3.7 Uu
9.3.8 Mh
9.3.9 Others
9.4 Gastrointestinal Tract Infections Testing
9.4.1 Group B Streptococcus
9.4.2 Shiga Toxin
9.4.3 H. Pylori
9.5 Others
10 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By End User
10.1 Overview
10.2 Laboratories
10.2.1 Polymerase Chain Reaction
10.2.2 Isothermal Amplification
10.3 Hospital
10.3.1 Polymerase Chain Reaction
10.3.2 Isothermal Amplification
10.4 Clinics
10.4.1 Polymerase Chain Reaction
10.4.2 Isothermal Amplification
10.5 Ambulatory Center
10.5.1 Polymerase Chain Reaction
10.5.2 Isothermal Amplification
10.6 Homecare
10.6.1 Polymerase Chain Reaction
10.6.2 Isothermal Amplification
10.7 Assisted Living Facilities
10.7.1 Polymerase Chain Reaction
10.7.2 Isothermal Amplification
10.8 Others
11 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing
11.1 Overview
11.2 Prescription-based Testing
11.3 Otc Testing
12 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel
12.1 Overview
12.2 Hospital Pharmacy
12.3 Retail Pharmacy
12.4 Online Pharmacy
13 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Region
13.1 Middle East
13.1.1 Saudi Arabia
13.1.2 U.A.E
13.1.3 Israel
13.1.4 Egypt
13.1.5 Rest Of Middle East
13.2 Africa
13.2.1 South Africa
13.2.2 Kenya
13.2.3 Nigeria
13.2.4 Rest Of Africa
14 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Company Landscape
14.1 Company Share Analysis: Middle East & Africa
15 Swot Analysis
16 Company Profile
16.1 Danaher
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Thermo Fisher Scientific Inc.
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 Bd
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 F.Hoffmann-la-roche Ltd.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Abbott
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Product Portfolio
16.5.4 Recent Developments
16.6 Binx Health, Inc.
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Development
16.7 Biomerieux Sa
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Development
16.8 Co-diagnostics, Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Genmark Diagnostics, Inc
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Development
16.10 Grifols, S.A.
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
16.11 Lucira Health Inc.
16.11.1 Company Snapshot
16.11.2 Product Portfolio
16.11.3 Recent Developments
16.12 Meridian Bioscience
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Developments
16.13 Quantumdx Group Ltd.
16.13.1 Company Snapshot
16.13.2 Product Portfolio
16.13.3 Recent Developments
16.14 Quidel Corporation
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Development
16.15 Sd Biosensor, Inc.
16.15.1 Company Snapshot
16.15.2 Product Portfolio
16.15.3 Recent Development
16.16 Sekisui Diagnostics (A Subsidiary Of Sekisui Medical)
16.16.1 Company Snapshot
16.16.2 Product Portfolio
16.16.3 Recent Development
16.17 Sysmex (A Subsidiary Of Sysmex Corporation
16.17.1 Company Snapshot
16.17.2 Revenue Analysis
16.17.3 Product Portfolio
16.17.4 Recent Development
16.18 Wondfo
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
17 Questionnaire
18 Related Reports 232
List Of Tables
Table 1 Cepheid: Annual Test Volume, For All Countries, 2020 (Units)
Table 2 Thermo Fisher Scientific Inc. : Annual Test Volume, For All Countries, 2020 (Units)
Table 3 Hologic, Inc. : Annual Test Volume, For All Countries, 2020 (Units)
Table 4 Bd : Annual Test Volume, For All Countries, 2020 (Units)
Table 5 F. Hoffmann-la Roche Ltd : Annual Test Volume, For All Countries, 2020 (Units)
Table 6 Number Of Poct Instruments Installed In Each Country, 2020 (Units)
Table 7 Distributors Across North America
Table 8 Distributors Across Europe
Table 9 Distributors Across South Asia
Table 10 Distributors Across South East Asia
Table 11 Distributors Across Middle East
Table 12 Distributors Across Africa
Table 13 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 14 Middle East & Africa Consumables & Reagents In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 15 Middle East & Africa Instruments In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 16 Middle East & Africa Instruments In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 17 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 18 Middle East & Africa Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 19 Middle East & Africa Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 20 Middle East & Africa Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 21 Middle East & Africa Sexually Transmitted In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 22 Middle East & Africa Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 23 Middle East & Africa Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 24 Middle East & Africa Others In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 25 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 26 Middle East & Africa Laborotories In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 27 Middle East & Africa Laborotories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 28 Middle East & Africa Hospital In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 29 Middle East & Africa Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 30 Middle East & Africa Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 31 Middle East & Africa Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 32 Middle East & Africa Ambulatory Center In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 33 Middle East & Africa Ambulatory Center In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 34 Middle East & Africa Home Care In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 35 Middle East & Africa Home Care In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 36 Middle East & Africa Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 37 Middle East & Africa Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 38 Middle East & Africa Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 39 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 40 Middle East & Africa Prescription-based Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region 2019-2028 (Usd Million)
Table 41 Middle East & Africa Otc Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 42 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 43 Middle East & Africa Hospital Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 44 Middle East & Africa Retail Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 45 Middle East & Africa Online Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 46 Middle East Molecular Point Of Care Testing (Using Naat) Market, By Country, 2019-2028 (Usd Million)
Table 47 Middle East Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 48 Middle East Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 49 Middle East Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 50 Middle East Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 51 Middle East Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 52 Middle East Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 53 Middle East Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 54 Middle East Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 55 Middle East Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 56 Middle East Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 57 Middle East Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 58 Middle East Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 59 Middle East Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 60 Middle East Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 61 Middle East Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 62 Saudi Arabia Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 63 Saudi Arabia Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 64 Saudi Arabia Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 65 Saudi Arabia Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 66 Saudi Arabia Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 67 Saudi Arabiagastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 68 Saudi Arabiamolecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 69 Saudi Arabia Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 70 Saudi Arabia Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 71 Saudi Arabia Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 72 Saudi Arabia Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 73 Saudi Arabia Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 74 Saudi Arabia Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 75 Saudi Arabia Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 76 Saudi Arabia Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 77 U.A.E Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 78 U.A.E Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 79 U.A.E Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 80 U.A.E Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 81 U.A.E Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 82 U.A.E Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 83 U.A.E Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 84 U.A.E Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 85 U.A.E Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 86 U.A.E Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 87 U.A.E Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 88 U.A.E Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 89 U.A.E Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 90 U.A.E Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 91 U.A.E Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 92 Israel Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 93 Israel Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 94 Israel Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 95 Israel Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 96 Israel Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 97 Israel Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 98 Israel Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 99 Israel Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 100 Israel Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 101 Israel Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 102 Israel Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 103 Israel Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 104 Israel Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 105 Israel Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 106 Israel Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 107 Egypt Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 108 Egypt Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 109 Egypt Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 110 Egypt Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 111 Egypt Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 112 Egypt Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 113 Egypt Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 114 Egypt Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 115 Egypt Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 116 Egypt Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 117 Egypt Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 118 Egypt Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 119 Egypt Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 120 Egypt Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 121 Egypt Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 122 Rest Of Middle East Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 123 Africa Molecular Point Of Care Testing (Using Naat) Market, By Country, 2019-2028 (Usd Million)
Table 124 Africa Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 125 Africa Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 126 Africa Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 127 Africa Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 128 Africa Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 129 Africa Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, Indication, 2019-2028 (Usd Million)
Table 130 Africa Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 131 Africa Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 132 Africa Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 133 Africa Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 134 Africa Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 135 Africa Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 136 Africa Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 137 Africa Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 138 Africa Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 139 South Africa Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million) 161
List Of Figures
Figure 1 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Segmentation
Figure 2 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Data Triangulation
Figure 3 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Droc Analysis
Figure 4 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Middle East & Africa Vs Regional Market Analysis
Figure 5 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Company Research Analysis
Figure 6 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Interview Demographics
Figure 7 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Multivariate Modelling
Figure 8 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Dbmr Market Position Grid
Figure 9 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Vendor Share Analysis
Figure 10 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: End User Overage Grid
Figure 11 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Segmentation
Figure 12 North America Is Expected To Dominate The Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market And Is Expected To Grow With The Highest Cagr In The Forecast Period
Figure 13 Increasing Prevalence Of Chronic Disease And Improving Diagnosis-seeking Rate Are Expected To Drive The Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market In The Forecast Period
Figure 14 Consumables And Reagents Segment Is Expected To Account For The Largest Share Of The Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market In 2021 & 2028
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market
Figure 16 Medical Device Spending Vs National Health Expenditures, 2016
Figure 17 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Product, 2020
Figure 18 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Product, 2021-2028 (Usd Million)
Figure 19 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Product, Cagr (2021-2028)
Figure 20 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Product, Lifeline Curve
Figure 21 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Indication, 2020
Figure 22 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Indication, 2021-2028 (Usd Million)
Figure 23 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Indication, Cagr (2021-2028)
Figure 24 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Indication, Lifeline Curve
Figure 25 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By End User, 2020
Figure 26 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By End User, 2021-2028 (Usd Million)
Figure 27 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By End User, Cagr (2021-2028)
Figure 28 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By End User, Lifeline Curve
Figure 29 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, 2020
Figure 30 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, 2021-2028 (Usd Million)
Figure 31 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, Cagr (2021-2028)
Figure 32 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, Lifeline Curve
Figure 33 Middle East & Africa Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, 2020
Figure 34 Middle East & Africa Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, 2021-2028 (Usd Million)
Figure 35 Middle East & Africa Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, Cagr (2021-2028)
Figure 36 Middle East & Africa Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, Lifeline Curve
Figure 37 Middle East Molecular Point Of Care Testing (Using Naat) Market: Snapshot (2020)
Figure 38 Middle East Molecular Point Of Care Testing (Using Naat) Market: By Country (2020)
Figure 39 Middle East Molecular Point Of Care Testing (Using Naat) Market: By Country (2021 & 2028)
Figure 40 Middle East Molecular Point Of Care Testing (Using Naat) Market: By Country (2020 & 2028)
Figure 41 Middle East Molecular Point Of Care Testing (Using Naat) Market: By Product (2021-2028)
Figure 42 Africa Molecular Point Of Care Testing (Using Naat) Market: Snapshot (2020)
Figure 43 Africa Molecular Point Of Care Testing (Using Naat) Market: By Country (2020)
Figure 44 Africa Molecular Point Of Care Testing (Using Naat) Market: By Country (2021 & 2028)
Figure 45 Africa Molecular Point Of Care Testing (Using Naat) Market: By Country (2020 & 2028)
Figure 46 Africa Molecular Point Of Care Testing (Using Naat) Market: By Product (2021-2028)
Figure 47 Middle East & Africa Molecular Point Of Care Testing (Using Naat) Market: Company Share 2020 (%) 176

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings